Effect of Unani drug on thyroid disease
Phase 2
- Conditions
- Health Condition 1: E02- Subclinical iodine-deficiency hypothyroidism
- Registration Number
- CTRI/2022/05/042682
- Lead Sponsor
- ATIONAL INSTITUTE OF UNANI MEDICINE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients between 20-60 years of age of either gender.
Cases with TSH level between 5.5 and 15 mIU/L & Serum free thyroxine (fT4) level within normal range.
Ability to provide written informed consent and understand the risks and benefits of the protocol.
Exclusion Criteria
Pregnancy and lactation.
Complicated cases of Hypothyroidism, Diabetes, Liver Disorders, stroke, depression, or other neurologic/psychiatric disorders
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in TSH levelTimepoint: 56 days
- Secondary Outcome Measures
Name Time Method safety assessment like â?¢AST, ALT <br/ ><br>â?¢KFT (Blood Urea Serum Creatinine) <br/ ><br> <br/ ><br>Timepoint: 56 days